Yesterday, 13:30

Curium Group, PeptiDream and PDRadiopharma Enroll First Patient to Registrational Clinical Trial of Lu-PSMA-I&T for Prostate Cancer in Japan

Notified -
Globe NewswireYesterday, 13:30
3-12-2025, 16:04

Curium Establishes Legal Entity in China

Notified -
Globe Newswire3-12-2025, 16:04
20-11-2025, 19:10

CapVest recapitalizes Curium to accelerate its growth strategy, marking the largest transaction in nuclear medicine globally

Notified -
Globe Newswire20-11-2025, 19:10
21-05-2025, 16:42

Curium and NRG PALLAS extend collaboration in the supply of essential medical isotope to hospitals

Notified -
Globe Newswire21-05-2025, 16:42
28-03-2025, 13:00

Curium Completes the Acquisition of Monrol as Part of its Plan to Significantly Expand Lutetium-177 Capacity and PET Footprint

Notified -
Globe Newswire28-03-2025, 13:00
16-11-2023, 17:14

Curium Announces First Patients in Europe Injected With PYLCLARI® – an Innovative 18F-PSMA Pet Tracer Indicated in Patients With Prostate Cancer
Globe Newswire16-11-2023, 17:14
25-10-2023, 18:33

Curium and PIUR IMAGING Announce Thyroid Imaging Partnership in Germany to Enable Tomographic 3D Ultrasound Solutions
Globe Newswire25-10-2023, 18:33